Characterization of two novel lytic bacteriophages for Klebsiella pneumoniae: molecular studies
Academia Molecular Biology and Genomics · 17.06.2026 · 3 (2)
DOI: 10.20935/acadmolbiogen8364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academia Molecular Biology and Genomics, online erschienen am 17.06.2026. Verfasst von Bruna R. Guerrero und 9 weiteren Autor:innen. Die Arbeit nennt 174 Literaturangaben.
Abstract (Originalsprache)
Introduction
Multidrug-resistant Klebsiella pneumoniae (Kpn) poses a growing global health threat due to its role in severe hospital-acquired infections and increasing resistance to antibiotics. The objective of this study was to isolate, characterize, and evaluate the therapeutic potential of two novel lytic bacteriophages targeting multidrug-resistant K. pneumoniae, aiming for the development of alternatives to conventional antibiotics. Materials and methods: Phages KpnS01BRG and KpnS02SCE were analyzed using transmission electron microscopy (TEM) and whole-genome sequencing (WGS). Replication kinetics were determined through single-step growth curves (latency period and burst size). Antibacterial efficacy was tested in vitro using a phage cocktail at a multiplicity of infection (MOI) of 10,000 over 12 h. Additionally, a genome mechanics analysis was conducted to evaluate viral DNA cyclizability and flexibility.
Results
TEM revealed that both phages belong to the class Caudoviricetes with a siphovirus-like morphology, and WGS classified them within the genus Webervirus (family Drexlerviridae). Phage KpnS01BRG exhibited a latency period of 60 min and a burst size of 17.7 virions/cell, while KpnS02SCE showed a latency of 5.8 min and a burst size of 18.6 virions/cell. The phage cocktail reduced the bacterial load by approximately 97.2% after 12 h, relative to the untreated control. Genomic analysis indicated that the higher DNA flexibility in KpnS02SCE correlated with a slightly higher virion production, corroborating previous findings on genome mechanics.
Conclusions
The novel phages demonstrated potent antibacterial activity (i.e., strongly reduced bacterial counts after 6 h) and favorable genomic characteristics, establishing themselves as promising candidates for phage-based therapeutic strategies against multidrug-resistant K. pneumoniae infections.
Zitieren
APA
Guerrero, B. R., Emencheta, S. C., Quinde, C. A., Cieza, B., Basu, A., Samir, S., Attama, A. A., Onuigbo, E. B., Vila, M. M. D. C., & Balcão, V. M. (2026). Characterization of two novel lytic bacteriophages for Klebsiella pneumoniae: molecular studies. Academia Molecular Biology and Genomics, 3(2). https://doi.org/10.20935/acadmolbiogen8364
Vancouver
Guerrero BR, Emencheta SC, Quinde CA, Cieza B, Basu A, Samir S, et al. Characterization of two novel lytic bacteriophages for Klebsiella pneumoniae: molecular studies. Academia Molecular Biology and Genomics. 2026;3(2). doi:10.20935/acadmolbiogen8364
BibTeX
@article{Guerrero2026,
author = {Guerrero, Bruna R. and Emencheta, Stephen C. and Quinde, Carlos A. and Cieza, Basilio and Basu, Aakash and Samir, Safia and Attama, Anthony A. and Onuigbo, Ebele B. and Vila, Marta M. D. C. and Balcão, Victor M.},
title = {Characterization of two novel lytic bacteriophages for Klebsiella pneumoniae: molecular studies},
journal = {Academia Molecular Biology and Genomics},
year = {2026},
volume = {3},
number = {2},
doi = {10.20935/acadmolbiogen8364}
}
EUVIMED